Načítá se...
Targeting tumor cells with antibodies enhances anti-tumor immunity
Tumor-targeting antibodies were initially defined as a group of therapeutic monoclonal antibodies (mAb) that recognize tumor-specific membrane proteins, block cell signaling, and induce tumor-killing through Fc-driven innate immune responses. However, in the past decade, ample evidence has shown tha...
Uloženo v:
| Vydáno v: | Biophys Rep |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6245233/ https://ncbi.nlm.nih.gov/pubmed/30533489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41048-018-0070-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|